Type 1 Diabetes And Pregnancy - Advanced Therapeutics (UK) Ltd

Adapting To Changing Needs

Navigating Type 1 diabetes and pregnancy requires precision and advanced technology. At Advanced Therapeutics (UK) Ltd, we understand the unique challenges expectant mothers face in managing their glucose levels. That’s why our Dana i insulin pump, featuring Hybrid Closed Loop Therapy with the CamAPS® FX app is an absolute game changer when it comes to Type 1 diabetes and pregnancy.

Our Dana CamAPS® FX Hybrid Closed Loop System has a specific license for use during pregnancy, and, following clinical study, it’s been recommended by top UK Diabetologists for use in all those experiencing or planning pregnancy. Our learning system makes insulin delivery decisions every 8-12 minutes, ensuring it readily adapts to the changing needs of your pregnant body.

Type 1 Diabetes And Pregnancy – The Challenges

For women with Type 1 diabetes, pregnancy brings about significant changes in insulin requirements. As pregnancy progresses, the body’s response to insulin alters, which means adjustments to both basal and bolus insulin delivery may be necessary, particularly before meals, to maintain stable blood glucose levels. In turn, you need a device that can keep up with these fluctuations.

Our Dana CamAPS® FX System is a learning, advanced hybrid closed loop algorithm that can automatically respond to your sensor glucose readings, predict future readings and adjust insulin delivery to ensure you remain within the target range. With a 300-unit cartridge, our system has been specially designed to meet the evolving insulin needs for those going through Type 1 diabetes and pregnancy. This generous cartridge capacity ensures a steady and reliable supply of insulin, which is a crucial factor around the 16-20 week mark and beyond. With variable speed of delivery, Dana CamAPS® FX ensure that no matter how large boluses get, they can be delivered without discomfort and maximising absorption under the skin.

Ensuring Optimal Glycaemic Control

The thought of Type 1 diabetes and pregnancy is often a daunting one for those looking to start or expand their families and optimising glycaemic control before and during pregnancy is of the utmost importance. Continuous Subcutaneous Insulin Infusion (CSII) with our Dana CamAPS® FX System proves invaluable in normalising blood glucose levels during this crucial time. The system’s learning algorithm continually refines insulin delivery decisions based on real-time and historic data, offering a level of precision that surpasses conventional methods for Type 1 diabetes and pregnancy. The CamAPS® FX algorithm is the only one of its kind licensed for use during pregnancy and it can also be used at any other time in a woman’s life. You can read more about what everyday life is like with a pump here.

As our system makes insulin delivery decisions every 8-12 minutes, it is also vital during the first trimester, when factors like morning sickness and hypoglycaemia with diminished warning signs may impact control. The Dana CamAPS® FX System provides the flexibility needed to maintain stable blood glucose levels, even in the face of these challenges during Type 1 diabetes and pregnancy.

During And Post-Delivery

During delivery, those with Type 1 diabetes can continue to use Dana CamAPS® FX, even in planned C-sections with approval from their relevant health care teams.

Following delivery, it is recommended by Camdiab that the PGT (Personal Glucose Target) is adjusted, and the ‘Ease Off’ feature is used in accordance with the advice from the healthcare professionals whilst the system adapts to post-delivery insulin requirements and lactation.

It will likely be recommended by your HCP’s that a reduced basal patten (pattern B) is programmed for emergency use post-delivery should the loop fail for any reason, and that you should switch to pattern B rates immediately after delivery for safety as this could come into play during any connection issued or sensor warm-up times, when the loop isn’t running.

Take Control Of Your Glucose Levels

Managing Type 1 diabetes and pregnancy requires a level of precision and adaptability that Advanced Therapeutics (UK) Ltd’s Dana CamAPS® FX System can provide. With its learning technology, 300-unit cartridge and unique licence for use during pregnancy, it stands as a pioneering solution for expectant mothers. Embrace the future of Type 1 diabetes management and embark on this extraordinary journey with confidence. Please feel free to contact us if you have any further questions about our device.